These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19294435

  • 1. Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.
    Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T.
    Clin Oral Investig; 2010 Feb; 14(1):35-41. PubMed ID: 19294435
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
    Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B.
    Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
    Ziebart T, Pabst A, Klein MO, Kämmerer P, Gauss L, Brüllmann D, Al-Nawas B, Walter C.
    Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
    [Abstract] [Full Text] [Related]

  • 4. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
    Cozin M, Pinker BM, Solemani K, Zuniga JM, Dadaian SC, Cremers S, Landesberg R, Raghavan S.
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
    Hagelauer N, Ziebart T, Pabst AM, Walter C.
    Clin Oral Investig; 2015 Jun; 19(5):1079-91. PubMed ID: 25261400
    [Abstract] [Full Text] [Related]

  • 6. Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw.
    Ziebart T, Koch F, Klein MO, Guth J, Adler J, Pabst A, Al-Nawas B, Walter C.
    Oral Oncol; 2011 Mar; 47(3):195-201. PubMed ID: 21247791
    [Abstract] [Full Text] [Related]

  • 7. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
    Pabst AM, Ziebart T, Koch FP, Taylor KY, Al-Nawas B, Walter C.
    Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
    [Abstract] [Full Text] [Related]

  • 8. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
    Jung J, Park JS, Righesso L, Pabst AM, Al-Nawas B, Kwon YD, Walter C.
    Clin Oral Investig; 2018 Sep; 22(7):2527-2534. PubMed ID: 29388023
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay.
    Pabst AM, Ziebart T, Ackermann M, Konerding MA, Walter C.
    Clin Oral Investig; 2014 Apr; 18(3):1015-22. PubMed ID: 23892503
    [Abstract] [Full Text] [Related]

  • 10. The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay.
    Pabst AM, Krüger M, Sagheb K, Ziebart T, Jacobs C, Blatt S, Goetze E, Walter C.
    Clin Oral Investig; 2017 Apr; 21(3):771-778. PubMed ID: 27170294
    [Abstract] [Full Text] [Related]

  • 11. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G.
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [Abstract] [Full Text] [Related]

  • 12. Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
    Otto M, Lux C, Schlittenbauer T, Halling F, Ziebart T.
    Oral Maxillofac Surg; 2022 Jun; 26(2):321-332. PubMed ID: 34392434
    [Abstract] [Full Text] [Related]

  • 13. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
    Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, Bauss F, Ehrenfeld M, Schieker M.
    J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
    [Abstract] [Full Text] [Related]

  • 14. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C, Wagner W.
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [Abstract] [Full Text] [Related]

  • 15. Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment.
    Simon MJ, Niehoff P, Kimmig B, Wiltfang J, Açil Y.
    Clin Oral Investig; 2010 Feb; 14(1):51-8. PubMed ID: 19597852
    [Abstract] [Full Text] [Related]

  • 16. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
    Oizumi T, Yamaguchi K, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y.
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
    [Abstract] [Full Text] [Related]

  • 17. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
    Açil Y, Möller B, Niehoff P, Rachko K, Gassling V, Wiltfang J, Simon MJ.
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
    [Abstract] [Full Text] [Related]

  • 18. Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo.
    Draenert GF, Huetzen DO, Kämmerer PW, Palarie V, Nacu V, Wagner W.
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e369-74. PubMed ID: 22429609
    [Abstract] [Full Text] [Related]

  • 19. In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
    Hagelauer N, Pabst AM, Ziebart T, Ulbrich H, Walter C.
    Clin Oral Investig; 2015 Jan; 19(1):139-48. PubMed ID: 24668343
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.